The present invention relates to novel to N-alkyl adamantyl triazinyl benzylamide
derivatives of formmula I:
##STR1##
and to processs for their preparation, intermediates useful in their preparation,
pharmaceutical compositions containing them, and their use in therapy. The active
compounds of the present invention are useful in the treatment of inflammation,
osteoarthritis, rhematoid arthritis, cancer, reperfusion or ischemia in stroke
or heart attack, autoimmune diseases and other disorders.
